Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you recommend high ozonated oil for radiation dermatitis?
Related Questions
How would you treat a schwannoma of the breast with a positive margin that is not amenable to re-excision?
Have the 10-year results from UK FAST-Forward presented at ESTRO 2025 impacted your practice with regard to patient selection?
Is it reasonable to extrapolate the findings of RT Charm and Alliance to intact breast patients and offer hypofractionated RNI to all patients who are eligible for RNI?
How would you manage an isolated nodal recurrence of breast cancer in a patient with a prior history of mantle-field radiation?
Do you boost a breast cavity for a high Ki-67 index in the absence of other risk factors?
Which patient subgroups do you plan to omit regional nodal irradiation for, given the publication of NSABP B-51?
Do you offer consolidative radiation for oligometastatic breast cancer?
Would you forgo lumpectomy cavity boost for grade 1 papillary carcinoma with associated grade 1 DCIS that has been resected with good margins?
What are your top takeaways in Breast Cancer from ASCO 2025?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?
